Spots Global Cancer Trial Database for A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting.
Official Title: A Study of Single Dose Intravenous Casopitant in Combination With Ondansetron and Dexamethasone for the Prevention of Oxaliplatin Induced Nausea and Vomiting.
Study ID: NCT00601172
Study Description
Brief Summary: This a Phase III trial designed to determine if IV casopitant plus dexamethasone and ondansetron is more effective in the prevention of vomiting and nausea then dexamethasone and ondansetrone alone following the administration of moderately emetogenic oxaliplatin-based chemotherapy.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
GSK Investigational Site, Hot Springs, Arkansas, United States
GSK Investigational Site, Corona, California, United States
GSK Investigational Site, Fountain Valley, California, United States
GSK Investigational Site, Riverside, California, United States
GSK Investigational Site, Saint Petersburg, Florida, United States
GSK Investigational Site, Tampa, Florida, United States
GSK Investigational Site, Alexandria, Louisiana, United States
GSK Investigational Site, Baton Rouge, Louisiana, United States
GSK Investigational Site, Baltimore, Maryland, United States
GSK Investigational Site, Boston, Massachusetts, United States
GSK Investigational Site, Worcester, Massachusetts, United States
GSK Investigational Site, Jefferson City, Missouri, United States
GSK Investigational Site, Great Falls, Montana, United States
GSK Investigational Site, Bronx, New York, United States
GSK Investigational Site, Winston-Salem, North Carolina, United States
GSK Investigational Site, Hilton Head Island, South Carolina, United States
GSK Investigational Site, Mount Pleasant, South Carolina, United States
GSK Investigational Site, Sumter, South Carolina, United States
GSK Investigational Site, Corpus Christi, Texas, United States
GSK Investigational Site, Corpus Christi, Texas, United States
GSK Investigational Site, Duncanville, Texas, United States
GSK Investigational Site, Ogden, Utah, United States
GSK Investigational Site, Burlington, Vermont, United States
GSK Investigational Site, Assebroek, , Belgium
GSK Investigational Site, Bonheiden, , Belgium
GSK Investigational Site, Gent, , Belgium
GSK Investigational Site, Ottignies, , Belgium
GSK Investigational Site, Shumen, , Bulgaria
GSK Investigational Site, Sofia, , Bulgaria
GSK Investigational Site, Varna, , Bulgaria
GSK Investigational Site, Sault Ste. Marie, Ontario, Canada
GSK Investigational Site, Thunder Bay, Ontario, Canada
GSK Investigational Site, Toronto, Ontario, Canada
GSK Investigational Site, Charlottetown, Prince Edward Island, Canada
GSK Investigational Site, Greenfield Park, Quebec, Canada
GSK Investigational Site, Laval, Quebec, Canada
GSK Investigational Site, Montreal, Quebec, Canada
GSK Investigational Site, Rimouski, Quebec, Canada
GSK Investigational Site, Sherbrooke, Quebec, Canada
GSK Investigational Site, Brno, , Czechia
GSK Investigational Site, Brno, , Czechia
GSK Investigational Site, Chomutov, , Czechia
GSK Investigational Site, Havlickuv Brod, , Czechia
GSK Investigational Site, Praha 10, , Czechia
GSK Investigational Site, Praha 8, , Czechia
GSK Investigational Site, Semily, , Czechia
GSK Investigational Site, Freiburg, Baden-Wuerttemberg, Germany
GSK Investigational Site, Ulm, Baden-Wuerttemberg, Germany
GSK Investigational Site, Aschaffenburg, Bayern, Germany
GSK Investigational Site, Augsburg, Bayern, Germany
GSK Investigational Site, Hof, Bayern, Germany
GSK Investigational Site, Muenchen, Bayern, Germany
GSK Investigational Site, Wuerzburg, Bayern, Germany
GSK Investigational Site, Bad Soden, Hessen, Germany
GSK Investigational Site, Kassel, Hessen, Germany
GSK Investigational Site, Braunschweig, Niedersachsen, Germany
GSK Investigational Site, Hannover, Niedersachsen, Germany
GSK Investigational Site, Essen, Nordrhein-Westfalen, Germany
GSK Investigational Site, Recklinghausen, Nordrhein-Westfalen, Germany
GSK Investigational Site, Wuerselen, Nordrhein-Westfalen, Germany
GSK Investigational Site, Magdeburg, Sachsen-Anhalt, Germany
GSK Investigational Site, Luebeck, Schleswig-Holstein, Germany
GSK Investigational Site, Pinneberg, Schleswig-Holstein, Germany
GSK Investigational Site, Jena, Thueringen, Germany
GSK Investigational Site, Hamburg, , Germany
GSK Investigational Site, Hamburg, , Germany
GSK Investigational Site, Budapest, , Hungary
GSK Investigational Site, Budapest, , Hungary
GSK Investigational Site, Gyula, , Hungary
GSK Investigational Site, Veszprém, , Hungary
GSK Investigational Site, Potenza, Basilicata, Italy
GSK Investigational Site, Rionero In Vulture (PZ), Basilicata, Italy
GSK Investigational Site, Reggio Calabria, Calabria, Italy
GSK Investigational Site, Avellino, Campania, Italy
GSK Investigational Site, Benevento, Campania, Italy
GSK Investigational Site, Napoli, Campania, Italy
GSK Investigational Site, Genova, Liguria, Italy
GSK Investigational Site, Sassari, Sardegna, Italy
GSK Investigational Site, Catania, Sicilia, Italy
GSK Investigational Site, Firenze, Toscana, Italy
GSK Investigational Site, Terni, Umbria, Italy
GSK Investigational Site, Padova, Veneto, Italy
GSK Investigational Site, Gyeonggi-do, , Korea, Republic of
GSK Investigational Site, Seoul, , Korea, Republic of
GSK Investigational Site, Seoul, , Korea, Republic of
GSK Investigational Site, Songpa-gu, Seoul, , Korea, Republic of
GSK Investigational Site, Kazan, , Russian Federation
GSK Investigational Site, Moscow Region, , Russian Federation
GSK Investigational Site, Moscow, , Russian Federation
GSK Investigational Site, Moscow, , Russian Federation
GSK Investigational Site, Samara, , Russian Federation
GSK Investigational Site, St. Petersburg, , Russian Federation
GSK Investigational Site, Banska Bystrica, , Slovakia
GSK Investigational Site, Bratislava, , Slovakia
GSK Investigational Site, Kosice, , Slovakia
GSK Investigational Site, Poprad, , Slovakia
Contact Details
Name: GSK Clinical Trials
Affiliation: GlaxoSmithKline
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
